Time Trends in the Incidence of Parkinson Disease.
暂无分享,去创建一个
W. Rocca | B. Grossardt | J. Ahlskog | R. Savica | J. Bower | James H Bower | J Eric Ahlskog | Walter A Rocca | Brandon R Grossardt | Rodolfo Savica | J. H. Bower | Walter A. Rocca
[1] W. Rocca,et al. Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. , 2013, JAMA neurology.
[2] I. Akushevich,et al. Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis. , 2013, Age and ageing.
[3] Kevin R. Sanft,et al. Chemical exposures and Parkinson's disease: A population‐based case–control study , 2006, Movement disorders : official journal of the Movement Disorder Society.
[4] Manjeet Singh,et al. Environmental Exposure to Pesticides and Neurodegenerative Diseases , 2012 .
[5] C. Tanner,et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.
[6] V. Calabrese,et al. PROJECTED NUMBER OF PEOPLE WITH PARKINSON DISEASE IN THE MOST POPULOUS NATIONS, 2005 THROUGH 2030 , 2007, Neurology.
[7] B Carstensen,et al. Age–period–cohort models for the Lexis diagram , 2007, Statistics in medicine.
[8] B. Yawn,et al. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. , 2012, Mayo Clinic proceedings.
[9] D. Maraganore,et al. Time trends in the incidence of parkinsonism in Olmsted County, Minnesota , 2001, Neurology.
[10] M. Goldacre,et al. Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson’s disease and epilepsy in English populations 1979–2006 , 2010, Journal of Neurology.
[11] M. Rossor,et al. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[12] Scott M. Brue,et al. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. , 2012, International journal of epidemiology.
[13] A. Singleton,et al. Meeting Report: Consensus Statement—Parkinson’s Disease and the Environment: Collaborative on Health and the Environment and Parkinson’s Action Network (CHE PAN) Conference 26–28 June 2007 , 2008, Environmental health perspectives.
[14] L. Escobedo,et al. Smoking prevalence in US birth cohorts: the influence of gender and education. , 1996, American journal of public health.
[15] M. Weisskopf,et al. Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970-2009. , 2013, American journal of epidemiology.
[16] A. Ascherio,et al. Variations in gender ratios support the connection between smoking and Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[17] Walter A. Rocca,et al. Risk factors for Parkinson's disease may differ in men and women: an exploratory study , 2013, Hormones and Behavior.
[18] K. Walters,et al. Time trends in incidence of Parkinson’s disease diagnosis in UK primary care , 2013, Journal of Neurology.
[19] P Sandroni,et al. Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.
[20] D. Maraganore,et al. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.
[21] L. Lix,et al. Socioeconomic variations in the prevalence and incidence of Parkinson's disease: a population-based analysis , 2009, Journal of Epidemiology & Community Health.
[22] U. C. Bureau,et al. Census of Population and Housing , 1993 .
[23] F. Gutzwiller,et al. Birth Cohort Effects in Neurological Diseases: Amyotrophic Lateral Sclerosis, Parkinson’s Disease and Multiple Sclerosis , 2012, Neuroepidemiology.
[24] I Litvan,et al. Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.
[25] A. Stein,et al. Early gestation as the critical time-window for changes in the prenatal environment to affect the adult human blood methylome , 2015, International journal of epidemiology.
[26] E. Mulvey,et al. Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. , 1995, Psychological bulletin.
[27] B. Boeve,et al. Incidence of dementia with Lewy bodies and Parkinson disease dementia. , 2013, JAMA neurology.
[28] D. Thurman,et al. How common are the “common” neurologic disorders? , 2007, Neurology.
[29] B. Yawn,et al. American Journal of Epidemiology Practice of Epidemiology Use of a Medical Records Linkage System to Enumerate a Dynamic Population over Time: the Rochester Epidemiology Project , 2022 .
[30] C. Griffiths,et al. Trends in Parkinson’s disease related mortality in England and Wales, 1993–2006 , 2009, European journal of neurology.
[31] M. Thun,et al. Temporal relationship between cigarette smoking and risk of Parkinson disease , 2007, Neurology.
[32] Mrc Psych,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop , 1996 .
[33] B. Yawn,et al. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. , 2012, Mayo Clinic proceedings.
[34] J. Dartigues,et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.